home icon Research Cancer Why this work is important


Why this work is important

Collaboration is key to transforming cancer research for Cheshire & Merseyside

Compared to the rest of the UK, Cheshire & Merseyside has some of the highest incidences of cancer. To illustrate the scale of the issue, In 2017, 15,259 people were diagnosed with cancer and 6,834 people died as a result of the disease.

The region also has lower than average rates of people taking part in national screening programmes for cancers including breast, cervical and prostate, which can lead to late diagnosis.  

However, cancer survival rates are improving and are now similar to the rest of the UK – a reflection of the care given to patients after cancer diagnosis.

Liverpool Health Partners’ Cancer Programme is bringing experts together to collaborate and transform research to drive down these incidences and improve outcomes for patients.

The aim is to address the needs of the local population and play to the region’s strengths and meet its potential.

The Cancer Strategy’s main aims are:

  • Build a collaborative cancer research community across the LHP research ecosystem that covers the entire patient pathway including prevention, screening, awareness, rapid diagnosis, treatment, living with and beyond cancer and end-of-life care.
  • Attract inward investment and high-calibre researchers to the region by creating translational research epicentres focussing on strategic themes and initiatives.
  • Increase clinical trial activity in all tumour types by identifying, encouraging and nurturing leadership and teamwork across partner organisations.
  • Build sustainable research capacity for all cancer-related specialities across the region by embedding research in the clinical service.